1.The value of ischemia-modified albumin in early diagnosis of acute myocardial infarction
Mingzheng XU ; Zhigang XI ; Guozhong YU ; Jifeng HE ; Quanyou LIU ; Jiting REN
Clinical Medicine of China 2011;27(10):1012-1014
Objective To investigate the value of ischemia modified albumin (IMA) detection in preliminary diagnosis of acute myocardial infarction (AMI).Methods The levels and variations of IMA,cTnI and CK-MB in 103 patients with acute chest pain were measured continuously at 0,4,6,12,24 hours after admission respectively.Thirty healthy subjects were observed as normal controls.Results Twenty three patients were diagnosed as AMI in the end,the sensitivity and specificity rates right after admission were 89.3% and91.3% for IMA,48.4% and 92.3% for CK-MB,30.6% and 93.7% for cTnI respectively.The sensitivity values at the 6th hours after admission were 91.3% for IMA,52.2% for CTnI and 34.8% for CK-MB respectively.The specificity was 100.0% when the IMA was detected in combination with CK-MB or cTnI.The sensitivity of co-detection was significantly higher than that any single detection at sixth hours after admission (x2 =15.99,P < 0.01 ).Conclusion Plasma IMA assessment is helpful for early diagnosis of AMI,and will significantly improve the sensitivity early diagnosis of AMI.The co-detection of IMA and CK-MB or cTnI obviously surpasses any single detection,and has extremely vital clinical significance.
2.Value of ischemia modified albumin detection method in the early diagnosis of acute coronary syndrome.
Mingzheng XU ; Zhigang XI ; Guozhong YU ; Jifeng HE ; Quanyou LIU ; Jiting REN
Clinical Medicine of China 2010;26(9):905-907
Objective To discuss the value of ischemia modified albumin (IMA) in the early diagnosis of acute coronary syndrome (ACS). Methods The IMA,cTnI, CK-MB and ECG were detected in 103 patients with suspected ACS (45 cases of NICP and 58 cases of ACS) within 5 hours of acute chest pain onset respectively. 30 healthy subjects were served as normal controls. Receiver operating characteristic (ROC) analysis was used to determine the optimal cutoff of this assay for identifying individuals with ACS from non-ischemic individuals (nonischemic chest pain, NICP). Results of IMA,cTnI,CK-MB and ECG were correlated with the final diagnosis and their diagnostic sensitivities for ACS were evaluated. Results The results suggested that acute phase IMA values between those with ACS and NICP were (89.66 ± 25.82) U/ml, (46.79 ± 17.20) U/ml respectively and showed significant difference. Area under the curve (AUC) of the ROC was 0.935. As the Cut-off point was 71.6 U/ml, the sensitivity, specificity, PPV and NPV of IMA were 90.6%, 71.4% , 82.8% and 83.3%, respectively. The simutanious positive rate of IMA for ischemia origin were 29.3% of cTnI,27.6% of CK-MB and 48.3% of ECG(P< 0.01). Conclusions Plasma IMA assessment is valuable for early diagnosis of acute coronary ischemia, and will improve the early diagnostic sensitivity of ACS significantly.
3.Modeling hepatoblastoma development with human fetal liver organoids reveals YAP1 activation is sufficient for tumorigenesis.
Li YANG ; Jin CHEN ; Jianqing LIANG ; Yufeng ZHANG ; Qingzhe WANG ; Xiaojun REN ; Jinsong WEI ; Qianchun GONG ; Jiting ZHANG ; Ning JIANG ; Xinhua LIN ; Jin LI ; Bing ZHAO
Protein & Cell 2022;13(9):683-688